The expression and clinical signiifcance of Stanniocalcin-1 in breast cancer

Zhaozhe Liu,Mingjun Yu,Fang Guo,Tao Han,Yaling Han,Dongchu Ma,Xiaodong Xie
DOI: https://doi.org/10.3760/cma.j.issn.1673-8799.2014.05.005
2014-01-01
Abstract:Objective To detect the expression of STC-1 mRNA and protein levels in cell lines and patients of breast cancer, and to investigate the clinical significance. Methods The reverse transcription polymerase chain reaction (RT-PCR) was used to detect STC-1mRNA in 3 breast cancer cell lines, the peripheral blood samples of 56 patients with breast cancer and 10 healthy women. The enzyme linked immunosorbent assay (ELISA) was used to detect STC-1 protein levels in supernatant of breast cancer cell lines, and in serum of 56 patients as well as 10 healthy women. Results The expression of STC-1 of breast cancer cells and patients with breast cancer were statistically higher than that of the healthy women in both mRNA and protein levels (P<0.05). The mRNA and protein levels of STC-1 in patients with breast cancer were related to the TNM stage (P<0.05), both were higher in stageⅣthan in stageⅠ,Ⅱ, andⅢ(P<0.05). The expression of STC-1 mRNA in lobular breast cancer was significantly higher than that in ductal breast cancer and breast mixed carcinoma (P=0.03). STC-1 mRNA and protein levels were higher when CEA>5 ng/ml than those when CEA≤5ng/ml(P<0.05). Conclusion STC-1 could be used as markers of recurrence and metastasis of breast cancer, and might be of great significance in judging prognosis.
What problem does this paper attempt to address?